Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]
News [2728]
Articles [201]
Editorials [1]
Conferences [136]
elearning [13]
Metformin's effect on breast cancer
Dr Vuk Stambolic - Ontario Cancer Institute, Toronto, Canada
Metformin's effect on breast cancer ( Dr Vuk Stambolic - Ontario Cancer Institute, Toronto, Canada )
13 Apr 2012
EGFR mutation unique to glioblastoma linked to lack of response
Dr Ingo Mellinghoff - Memorial Sloan-Kettering Cancer Center, New York, USA
EGFR mutation unique to glioblastoma linked to lack of response ( Dr Ingo Mellinghoff - Memorial Sloan-Kettering Cancer Center, New York, USA )
13 Apr 2012
Mouse models of metastatic breast cancer
Prof Jos Jonkers - Netherlands Cancer Institute, Amsterdam
Mouse models of metastatic breast cancer ( Prof Jos Jonkers - Netherlands Cancer Institute, Amsterdam )
4 Apr 2012
Recent advances in multiple myeloma therapy
Prof San Miguel, Prof Philippe Moreau, Prof Antonio Palumbo, Prof Meletios...
Recent advances in multiple myeloma therapy ( Prof San Miguel, Prof Philippe Moreau, Prof Antonio Palumbo, Prof Meletios Dimopoulos and Prof Thierry Facon )
14 Feb 2012
Recent advances in non-Hodgkin’s lymphoma therapy
Prof Mathias Rummel, Prof Umberto Vitolo, Prof Georg Hess, Prof Finbarr Cotter
Recent advances in non-Hodgkin’s lymphoma therapy ( Prof Mathias Rummel, Prof Umberto Vitolo, Prof Georg Hess, Prof Finbarr Cotter )
14 Feb 2012
Evolving treatment options in castration-resistant prostate cancer
Prof Gordon Mcvie, Prof Johann De Bono, Prof Bertrand Tombal, Prof Juergen...
Evolving treatment options in castration-resistant prostate cancer ( Prof Gordon Mcvie, Prof Johann De Bono, Prof Bertrand Tombal, Prof Juergen Gschwend, Dr Maria De Santis )
3 Feb 2012
ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma
Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group
ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma ( Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group )
9 Jan 2012
Cereblon expression required for anti-myeloma activity of lenalidomide and...
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Cereblon expression required for anti-myeloma activity of lenalidomide and pomalidomide ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
9 Jan 2012
The latest for Multiple Myeloma
Prof Paul Richardson - Dana Farber Institute, Boston, USA
The latest for Multiple Myeloma ( Prof Paul Richardson - Dana Farber Institute, Boston, USA )
19 Dec 2011
Update and new perspectives in the management of MDS
Dr Mikkael Sekeres – Cleveland Clinic Taussig Institute, USA
Update and new perspectives in the management of MDS ( Dr Mikkael Sekeres – Cleveland Clinic Taussig Institute, USA )
19 Dec 2011
Indolent non-Hodgkin’s Lymphoma in 2011: A game changing year
Dr Mathias Rummel - University Hospital, Giessen, Germany, Prof John Gribben –...
Indolent non-Hodgkin’s Lymphoma in 2011: A game changing year ( Dr Mathias Rummel - University Hospital, Giessen, Germany, Prof John Gribben – Barts and The London Trust Cancer Centre, UK and Prof Gilles Salles - Universite Claude Bernard Lyon, France )
16 Dec 2011
The changing landscape for NHL treatment
Prof Bertrand Coiffier - Hospices Civils de Lyon, France
The changing landscape for NHL treatment ( Prof Bertrand Coiffier - Hospices Civils de Lyon, France )
16 Dec 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation